These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31185088)
1. Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina. Carroll LS; Uehara H; Fang D; Choi S; Zhang X; Singh M; Sandhu Z; Cummins PM; Curtis TM; Stitt AW; Archer BJ; Ambati BK Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2494-2502. PubMed ID: 31185088 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy. Cahoon JM; Rai RR; Carroll LS; Uehara H; Zhang X; O'Neil CL; Medina RJ; Das SK; Muddana SK; Olson PR; Nielson S; Walker K; Flood MM; Messenger WB; Archer BJ; Barabas P; Krizaj D; Gibson CC; Li DY; Koh GY; Gao G; Stitt AW; Ambati BK Diabetes; 2015 Dec; 64(12):4247-59. PubMed ID: 26340930 [TBL] [Abstract][Full Text] [Related]
3. Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration. Lambert NG; Zhang X; Rai RR; Uehara H; Choi S; Carroll LS; Das SK; Cahoon JM; Kirk BH; Bentley BM; Ambati BK Exp Eye Res; 2016 Apr; 145():248-257. PubMed ID: 26775053 [TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice. Yang XF; Huang YX; Lan M; Zhang TR; Zhou J Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384 [TBL] [Abstract][Full Text] [Related]
5. LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice. Hossain A; Tauhid L; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Ahmed SA; Bhattacharjee PS Curr Eye Res; 2017 Apr; 42(4):640-647. PubMed ID: 27442082 [TBL] [Abstract][Full Text] [Related]
6. The Ins2Akita mouse as a model of early retinal complications in diabetes. Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643 [TBL] [Abstract][Full Text] [Related]
7. Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for erectile dysfunction in the type II diabetic db/db mouse. Jin HR; Kim WJ; Song JS; Piao S; Tumurbaatar M; Shin SH; Choi MJ; Tuvshintur B; Song KM; Kwon MH; Yin GN; Koh GY; Ryu JK; Suh JK J Sex Med; 2010 Nov; 7(11):3635-46. PubMed ID: 20584113 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy. Song B; Kim D; Nguyen NH; Roy S Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614 [TBL] [Abstract][Full Text] [Related]
9. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy. Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793 [TBL] [Abstract][Full Text] [Related]
11. Local delivery of COMP-angiopoietin 1 accelerates new bone formation in rat calvarial defects. Lim SS; Kook SH; Bhattarai G; Cho ES; Seo YK; Lee JC J Biomed Mater Res A; 2015 Sep; 103(9):2942-51. PubMed ID: 25727390 [TBL] [Abstract][Full Text] [Related]
12. Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy. Wang J; Cui X; Roon P; Smith SB Invest Ophthalmol Vis Sci; 2016 May; 57(6):2770-81. PubMed ID: 27206247 [TBL] [Abstract][Full Text] [Related]
13. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy. Kim D; Mecham RP; Nguyen NH; Roy S Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398 [TBL] [Abstract][Full Text] [Related]
14. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2 Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085 [TBL] [Abstract][Full Text] [Related]
15. Adeno-Associated Viral Vector 2 and 9 Transduction Is Enhanced in Streptozotocin-Induced Diabetic Mouse Retina. Lee SH; Yang JY; Madrakhimov S; Park HY; Park K; Park TK Mol Ther Methods Clin Dev; 2019 Jun; 13():55-66. PubMed ID: 30666309 [TBL] [Abstract][Full Text] [Related]
16. Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse. Jin HR; Kim WJ; Song JS; Piao S; Choi MJ; Tumurbaatar M; Shin SH; Yin GN; Koh GY; Ryu JK; Suh JK Diabetes; 2011 Mar; 60(3):969-80. PubMed ID: 21270241 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Kim YH; Kim YS; Roh GS; Choi WS; Cho GJ Acta Ophthalmol; 2012 Feb; 90(1):e31-7. PubMed ID: 21914146 [TBL] [Abstract][Full Text] [Related]
18. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats. Sima J; Ma J; Zhang SX; Guo J Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159 [TBL] [Abstract][Full Text] [Related]
19. Factors governing the transduction efficiency of adeno-associated virus in the retinal ganglion cells following intravitreal injection. Cao X; Yung J; Mak H; Leung CKS Gene Ther; 2019 Apr; 26(3-4):109-120. PubMed ID: 30692605 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]